Group One Trading’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Group One Trading’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,110	Closed	-$665	–	8498
2023 Q1	$665	Sell	5,110 -17,277	-77%	-$3.51K	﹤0.01%	6858
2022 Q4	$3.67K	Sell	22,387 -13,204	-37%	-$5.53K	﹤0.01%	6464
2022 Q3	$23K	Sell	35,591 -21,800	-38%	-$32.1K	﹤0.01%	5991
2022 Q2	$139K	Sell	57,391 -13,300	-19%	-$37K	﹤0.01%	4673
2022 Q1	$286K	Sell	70,691 -2,436	-3%	-$13.4K	﹤0.01%	4427
2021 Q4	$586K	Buy	73,127 +8,953	+14%	+$105K	﹤0.01%	3942
2021 Q3	$1.24M	Buy	+64,174	New	+$1.12M	﹤0.01%	3182

Other funds holding PLXP

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return

Group One Trading's PLXP Position: Q2 2023 in Review

Group One Trading sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2023, closing a stake of 5,110 shares — an estimated $665 sold.

Group One Trading first reported a position in PLXP in Q3 2021 and held it in 7 quarters. The position peaked at $1.24M in Q3 2021. 4 funds tracked by Wall St. Rank hold PLXP as of Q2 2023.

Group One Trading reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Group One Trading sold 5,110 PLx Pharma Inc. Common Stock shares in Q2 2023, an estimated $665.
Group One Trading first reported a position in PLx Pharma Inc. Common Stock in Q3 2021 and held it in 7 quarters.
Group One Trading's PLx Pharma Inc. Common Stock position peaked at $1.24M in Q3 2021.
4 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2023.

Based on Group One Trading's 13F filing for Q2 2023, filed 9 Aug 2023.